Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Benign Breast Neoplasm|Ductal Breast Carcinoma In Situ|Invasive Breast Carcinoma|Lobular Breast Carcinoma In Situ|Paget Disease of the Breast|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: Docosahexaenoic Acid|OTHER: Placebo
Sponsor: National Cancer Institute (NCI)